US Wound Co™ is committed to a bright future of faster, more effective treatment, both of chronic, diseased wounds, external and internal incisions and other procedures as well as day-to-day first aid.
Let’s work together to create the future of acute wound care!
Today, US Wound Co™ is charting a new direction to increase its presence in the acute marketplace by introducing AcutaRex™.
Everyday wounds,including most hospital surgeries and out-patient procedures will be greatly reduced in time required for closure by AcutaRex™ products.
Wounds heal faster with full closure results with AcutaRex™
Continue The TourUS Wound Co™ manages a portfolio of accute wound care products to be marketed and sold under the name AcutaRex™.
The efficacy of the basic ingredients used in AcutaRex™ has been proven to assist in the rapid healing of accute wounds.
We have assembled a world class team to create future of faster, more effective treatment, both of chronic, diseased wounds, external and internal incisions and other procedures as well as day-to-day first aid.
AcutaRex™ is a product physicians and pharmacists can trust for their patients and customers health through consistent product performance.
AcutaRex™ allows for substantial cost savings by reducing the time required for wound site closure.
Acute wound care amounts to over 70% of the total wound care market compared to 30% for chronic care.
AcutaRex™ is in a gel form and applied to topical wounds and surgical incisions.
A reduction in health care costs and the resulting private sector stimulus.
Increased productivity in the workforce.
Is dedicated to reducing patient suffering from wounds and seek to develop technologies that improve the quality of life for mankind.
USWoundCo was proud to have been selected by the Texas delegation for the 3rd year in a row. We had a blast and made numerous connections eager learn more about us, our vision and AcutaRex™
June 3-6, 2019 | Philadelphia, PA
